Comparison of the efficacy of tacrolimus 0.1% ointment vs calcipotriol/betamethasone in combination with NBUVB in treatment of vitiligo-Reference-Cited by-同舟云学术

Comparison of the efficacy of tacrolimus 0.1% ointment vs calcipotriol/betamethasone in combination with NBUVB in treatment of vitiligo

Published:2023-08-30 Issue:1 Volume:34 Page:
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Alshiyab Diala¹^ORCID,Al-qarqaz Firas¹^ORCID,Ba-shammakh Saleh²^ORCID,Al-Fakih Abdulqudos³^ORCID,Altawalbeh Aya¹,Alsheyab Safa’⁴^ORCID,Sarakbi Danyah¹,Muhaidat Jihan¹^ORCID

Affiliation:

1. Department of Dermatology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan

2. Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan

3. Department of Public Health, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan, Irbid, Jordan

4. Department of Mathematics and Statistics, Jordan University of Science and Technology, Irbid, Jordan

Funder

Jordan University of Science and Technology

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2023.2252119

Reference21 articles.

1. Vitiligo: A Review

2. A review of the worldwide prevalence of vitiligo in children/adolescents and adults

3. Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA

4. Psychodermatology of vitiligo: Psychological impact and consequences

5. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical efficacy of CO2 fractional laser combined with compound betamethasone in treating vitiligo and its impact on inflammatory factors;Frontiers in Medicine;2024-07-10

2. Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trial;Journal of Dermatological Treatment;2023-12-21